ACSL4 and breast carcinoma: The high ACSL4/low GPX4 profile holds significant practical value in predicting pathological complete response to neoadjuvant chemotherapy in breast cancer.A strategy to enhance chemosensitivity through the induction of ferroptosis has been identified.